ImmunityBio
IBRX
IBRX
126 hedge funds and large institutions have $196M invested in ImmunityBio in 2022 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 50 increasing their positions, 26 reducing their positions, and 23 closing their positions.
Holders
126
Holders Change
-5
Holders Change %
-3.82%
% of All Funds
2.18%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
18
Increased
50
Reduced
26
Closed
23
Calls
$3.07M
Puts
$3.79M
Net Calls
-$722K
Net Calls Change
-$627K
Top Buyers
| 1 |
1
State Street
Boston,
Massachusetts
|
$33M |
| 2 |
2
Vanguard Group
Malvern,
Pennsylvania
|
$40.2M |
| 3 |
3
JPMorgan Chase & Co
New York
|
$7.77M |
| 4 |
4
Citigroup
New York
|
$1.86M |
| 5 |
5
Geode Capital Management
Boston,
Massachusetts
|
$9.55M |
